Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value: $5.058B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 26,250,000 | $930M | 18.4% | $12.41 | — | Common | 452907108 |
| — | MIRATI THERAPEUTICS INC | 4,286,765 | $489M | 9.7% | $28.94 | — | Common | 60468T105 |
| — | HORIZON THERAPEUTICS PLC | 6,000,000 | $333M | 6.6% | $32.08 | — | Common | G46188101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 10,361,039 | $284M | 5.6% | $13.29 | +147.4% | Common | 462260100 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,675,000 | $269M | 5.3% | $108.54 | +25.4% | Common | 803607100 |
| ASND | ASCENDIS PHARMA | 1,750,000 | $259M | 5.1% | $42.74 | — | Sponsored ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,850,000 | $228M | 4.5% | $84.64 | +17.4% | Common | 09061G101 |
| ARGX | ARGENX SE | 970,000 | $218M | 4.3% | $67.74 | — | Sponsored ADR | 04016X101 |
| — | MYOKARDIA INC | 1,880,000 | $182M | 3.6% | $62.23 | — | Common | 62857M105 |
| FOLD | AMICUS THERAPEUTICS INC | 11,000,000 | $166M | 3.3% | $10.45 | +16.6% | Common | 03152W109 |
| — | ADVERUM BIOTECHNOLOGIES INC | 7,585,000 | $158M | 3.1% | $11.19 | — | Common | 00773U108 |
| — | MERSANA THERAPEUTICS INC | 6,500,000 | $152M | 3.0% | $23.40 | — | Common | 59045L106 |
| — | KARYOPHARM THERAPEUTICS INC | 7,000,000 | $133M | 2.6% | $11.13 | — | Common | 48576U106 |
| — | CONSTELLATION PHARMACEUTICALS INC | 4,000,000 | $120M | 2.4% | $45.62 | — | Common | 210373106 |
| — | DECIPHERA PHARMACEUTICALS INC | 1,860,000 | $111M | 2.2% | $46.44 | — | Common | 24344T101 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 10,000,000 | $100M | 2.0% | $10.01 | — | Sponsored ADR | 00653A107 |
| — | ACCELERON PHARMA INC | 1,040,000 | $99.08M | 2.0% | $90.80 | — | Common | 00434H108 |
| QURE | UNIQURE NV | 1,500,000 | $67.59M | 1.3% | $55.50 | +6.4% | Common | N90064101 |
| RLMD | RELMADA THERAPEUTICS INC | 1,425,000 | $63.77M | 1.3% | $40.70 | +3.9% | Common | 75955J402 |
| — | ZOGENIX INC | 2,250,000 | $60.77M | 1.2% | $34.80 | — | Common | 98978L204 |
| — | ARENA PHARMACEUTICALS INC | 950,000 | $59.8M | 1.2% | $62.95 | — | Common | 040047607 |
| — | ATHENEX INC | 3,850,000 | $52.98M | 1.0% | $18.13 | — | Common | 04685N103 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,128,594 | $48.33M | 1.0% | $26.57 | +36.1% | Common | 019770106 |
| CUE | CUE BIOPHARMA INC | 1,870,000 | $45.83M | 0.9% | $10.47 | +130.6% | Common | 22978P106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 350,000 | $39.64M | 0.8% | $153.98 | -36.1% | Common | 558868105 |
| — | TRILLIUM THERAPEUTICS INC | 4,750,000 | $38.43M | 0.8% | $4.04 | — | Common | 89620X506 |
| — | AVADEL PHARMACEUTICALS PLC | 4,565,655 | $36.89M | 0.7% | $7.95 | — | Sponsored ADR | 05337M104 |
| — | IVERIC BIO INC | 7,100,000 | $36.21M | 0.7% | $5.10 | — | Common | 46583P102 |
| XENE | XENON PHARMACEUTICALS INC | 2,800,000 | $35.11M | 0.7% | $9.61 | +32.4% | Common | 98420N105 |
| — | MARINUS PHARMACEUTICALS INC | 11,960,000 | $30.38M | 0.6% | $2.34 | — | Common | 56854Q101 |
| AUPH | AURINIA PHARMACEUTICALS INC | 1,670,000 | $27.14M | 0.5% | $17.64 | -9.2% | Common | 05156V102 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 525,000 | $22.13M | 0.4% | $30.22 | +21.8% | Common | 09203E105 |
| — | RETROPHIN INC | 1,050,000 | $21.43M | 0.4% | $20.41 | — | Common | 761299106 |
| — | CYMABAY THERAPEUTICS INC | 5,250,000 | $18.32M | 0.4% | $5.32 | — | Common | 23257D103 |
| KURA | KURA ONCOLOGY INC | 1,050,000 | $17.11M | 0.3% | $14.42 | 0.0% | Common | 50127T109 |
| RNAM | AVIDITY BIOSCIENCES INC | 585,000 | $16.53M | 0.3% | $28.83 | 0.0% | Common | 05370A108 |
| — | TRICIDA INC | 600,000 | $16.49M | 0.3% | $32.26 | — | Common | 89610F101 |
| PTCT | PTC THERAPEUTICS INC | 324,750 | $16.48M | 0.3% | $50.35 | -2.4% | Common | 69366J200 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,670,000 | $13.95M | 0.3% | $9.85 | -24.5% | Common | 31447P100 |
| — | AMARIN CORP PLC | 2,000,000 | $13.84M | 0.3% | $16.24 | — | Sponsored ADR | 023111206 |
| RVMD | REVOLUTION MEDICINES INC | 304,000 | $9.597M | 0.2% | $27.68 | +13.6% | Common | 76155X100 |
| — | BIODELIVERY SCIENCES INTL | 2,034,900 | $8.872M | 0.2% | $3.56 | — | Common | 09060J106 |
| CRDF | CARDIFF ONCOLOGY INC | 1,000,000 | $5.01M | 0.1% | $2.05 | 0.0% | Common | 14147L108 |
| — | ALIMERA SCIENCES INC | 415,999 | $2.621M | 0.1% | $7.58 | — | Common | 016259202 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 200,000 | $70,000 | 0.0% | $10.01 | — | Call | 00653A107 |